NCT01131000View on ClinicalTrials.gov

Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Fever
Interventions
DRUG

Ibuprofen

Intravenous ibuprofen, 100 mg, Single-dose

DRUG

Ibuprofen

Intravenous ibuprofen, 200mg, single dose

DRUG

Ibuprofen

Intravenous ibuprofen, 400 mg, Single-dose

OTHER

Normal Saline

Normal Saline, 100 ml, Single-dose

Trial Locations (11)

2305

Newcastle Mater Misericordiae Hospital, New Lambton

10700

Mahidol University Siriraj Hospital, Bangkok

27157

Wake Forest University Health Sciences, Winston-Salem

27401

Moses H. Cone Memorial Hospital, Greensboro

32806

Orlando Regional Medical Center, Orlando

37203

Vanderbilt University Medical Center, Nashville

37207

Skyline Medical Center, Nashville

38104

Methodist Healthcare - University Hospital, Memphis

63110

Barnes Jewish Hospital, St Louis

77030

Ben Taub General Hospital, Houston

Unknown

Flinders Medical Centre, Adelaide

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY